Apa itu Kontrol Miopia?
Kontrol Miopia berarti memperlambat perkembangan miopia (rabun jauh). Tanpa kontrol, biasa terjadi peningkatan 100-150 derajat per tahun. Kami memulai skrining miopia pada usia 3 tahun karena kami ingin mendeteksi dan mengontrol miopia segera setelah miopia terjadi.
Selain itu, Organisasi Kesehatan Dunia telah mengakui miopia sebagai masalah publik, merilis laporan bersama dengan Brien Holden Vision Institute pada tahun 2016[v].
Miopia terjadi karena bola mata memanjang. Semakin panjang bola mata, semakin tinggi miopia (resep kacamata). Selanjutnya, seiring bertambahnya usia anak, panjang bola mata juga cenderung bertambah. Oleh karena itu, dianjurkan untuk mengadopsi kontrol miopia sedini mungkin untuk mengurangi risiko kondisi yang disebutkan di atas.
Apa saja pilihannya?
Penelitian telah menunjukkan bahwa Lensa Kacamata Kontrol Miopia (mis. Bi-Fokal, MiyoSmart, MyoKids, MyoPilux MyoVision, Stellest, dll.) dapat memperlambat perkembangan miopia hingga 67% [vi] [vii] [viii] [ix] [xi]dibandingkan dengan kacamata konvensional.
Pilihan ini cocok untuk individu dengan miopia hingga -10.00D dengan astigmatisme -4.00D.
Beberapa penelitian[xii] [xiii] [xiv] [xv] [xvi] [xvii] [xviii] [xix] [xx] [xxi] telah menunjukkan kontrol miopia yang efektif dengan orto-keratologi. Selain itu, opsi ini memungkinkan seseorang untuk menikmati kebebasan dari kacamata siang hari atau lensa kontak. Ini bagus untuk berolahraga dan bagi mereka yang tidak suka memakai kacamata.
Penelitian telah menunjukkan perlambatan perkembangan miopia hingga 59%[xxii] [xxiii] [xxiv] [xxv] [xxvi] [xxvii] [xxviii] [xxix] [xxx] [xxxi] [xxxii] [xxxiii] dengan lensa Kontak Lunak Multi-Fokal/Kontrol Miopia Khusus (misalnya lensa lunak ArtMost OK, Mi-Sight, Naturalvue Multifocal, dll.).
Ini adalah pilihan ideal bagi individu yang tidak suka memakai lensa ortho k dan tidak menyukai kacamata. Cocok untuk individu dari segala usia (tidak terbatas pada anak-anak) dan dengan miopia hingga -15.00D dan astigmatisme hingga -1.50D.
Ini adalah beberapa produk yang ada di pasaran pada masa ini
Tetes mata atropin adalah pendekatan alternatif untuk kontrol miopia. Mereka tidak mengembalikan penglihatan yang sempurna, tetapi mereka membantu memperlambat perkembangan miopia.
Pendekatan khusus manapun untuk mengelola miopia pada anak-anak, harus dikombinasikan dengan gaya hidup sehat untuk mencapai hasil pengobatan yang diinginkan.
Makanan untuk Penglihatan Sehat
8 Tips untuk Kesehatan Mata
Aturan 20-20-20
Saran Lingkungan Visual
References
[i] Holden BA, Jong M, Davis S et al. Nearly 1 billion myopes at risk of myopia-related sight-threatening conditions by 2050 – time to act now. Clin Exp Optom. 2015;98:491-3.
[ii] Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60.
[iii] Wu L, Sun X, Zhou X, Weng C. Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009. BMC Ophthalmol. 2011;11:10.
[iv] Iwase A, Araie M, Tomidokoro A et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology. 2006;113:1354-62.
[v] World Health Organization. The impact of myopia and high myopia. 2016 Report.
[vi] Huang, J.et al. “Efficacy Comparison of 16 Interventions for Myopia Control in 28 Children: A Network Meta-Analysis”. Ophthalmology 2016, 123 (4), 697–708) 29
[vii] Sankaridurg, P.; Donovan, L.; Varnas, S.; Ho, A.; Chen, X.; Martinez, A.; Fisher, S.; Lin, Z.; Smith, E. L.; Ge, J.; Holden, B.; Holden, B. “Spectacle Lenses Designed to Reduce Progression of Myopia: 12-Month Results.” Optom. Vis. Sci. 2010, 87 (9), 631
[viii] Schilling T, Ohlendorf A, Varnas SR, Wahl S. “Peripheral design of progressive addition lenses and the lag of 57 accommodation in myopes.” Invest Ophthalmol Vis Sci. 2017;58:3319–3324
[ix] Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
[x] Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Stellest™ lenses compared to 50 myopic children wearing single vision lenses. Results based on 32 children who declared wearing Essilor® Stellest™ lenses at least 12 hours per day every day. Bao, J. et al. (2021). One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br. J. Ophthalmol. doi:10.1136/bjophthalmol-2020-318367
[xi] Compared to single vision lenses, when worn 12 hours a day. Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor® Stellest™ lenses compared to 50 myopic children wearing single vision lenses. Efficacy results based on 32 children who declared wearing Stellest™ lenses at least 12 hours per day every day. Bao J. et al. (2021). Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial. Invest. Ophthalmol. Vis. Sci.; 62(8):2888.
[xii] Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 2015 Apr 9;10(4):e0124535.
[xiii] Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Investigative ophthalmology & visual science. 2013 Oct 1;54(10):6510-7.
[xiv] Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013 Jun;90(6):530-9.
[xv] Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005;30:71–80. doi: 10.1080/02713680590907256
[xvi] Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol. 2009;93:1181–1185. doi: 10.1136/bjo.2008.151365
[xvii] Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011;52:2170–2174. doi: 10.1167/iovs.10-5485.
[xviii] Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53:7077–7085. doi: 10.1167/iovs.12-10565.
[xix] Hiraoka T, Kakita T, Okamoto F, et al. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3913–3919. doi: 10.1167/iovs.11-8453.
[xx] Mok AK-H, Chung CS-T. Seven-year retrospective analysis of the myopic control effect of orthokeratology in children: a pilot study. Clin Optom. 2011;3:1–4.
[xxi] Downie LE, Lowe R. Corneal reshaping influences myopic prescription stability (CRIMPS): an analysis of the effect of orthokeratology on childhood myopic refractive stability. Eye & Contact Lens: Science & Clinical Practice. 2013;39:303–310. doi: 10.1097/ICL.0b013e318298ee76.
[xxii] Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567
[xxiii] Chamberlain P, et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. Presentation at BCLA 2019, Manchester, England.
[xxiv] Frank Spors, et al. In-Vivo Evaluation of Peripheral Refraction with Single Vision and Multifocal Soft Contact Lenses, ARVO 2018 Poster
[xxv] Walline, JJ; Walker, MK; Mutti, DO; Jones-Jordan, LA; Sinnott, LT; Gaume Giannoni, A; Bickle, KM; Schulle, KL; Nixon, A; Pierce, GE; Berntsen, DA “Effect of high add power, medium add power, or single vision contact lenses on myopia progression in children: the BLINK randomized clinical trial,” published August 11, 2020 in JAMA. DOI: 10.1001/jama.2020.10834
[xxvi] Li, L., Moody, K., Tan, D. T. H., Yew, K. C., Ming, P. Y., & Long, Q. B. (2009). Contact lenses in pediatrics study in Singapore. Eye & Contact Lens, 35(4), 188–195.
[xxvii] Walline, J. J., Long, S., & Zadnik, K. (2004). Daily disposable contact lens wear in myopic children. Optometry and Vision Science: Official Publication of the American Academy of Optometry, 81(4), 255–259.
[xxviii] Horner, D. G., Soni, P. S., Salmon, T. O., & Swartz, T. S. (1999). Myopia progression in adolescent wearers of soft contact lenses and spectacles. Optometry and Vision Science: Official Publication of the American Academy of Optometry, 76(7), 474–479.
[xxix] .Walline, J. J., Jones, L. A., Sinnott, L., Manny, R. E., Gaume, A., Rah, M. J., … ACHIEVE Study Group. (2008). A randomized trial of the effect of soft contact lenses on myopia progression in children. Investigative Ophthalmology & Visual Science, 49(11), 4702–4706.
[xxx] Aller, T. A., & Wildsoet, C. (2008). Bifocal soft contact lenses as a possible myopia control treatment: a case report involving identical twins. Clinical & Experimental Optometry: Journal of the Australian Optometrical Association, 91(4), 394–399.
[xxxi] Anstice, N. S., & Phillips, J. R. (2011). Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology, 118(6), 1152–1161.
[xxxii] Aller, T. A., Liu, M., & Wildsoet, C. F. (2016). Myopia Control with Bifocal Contact Lenses: A Randomized Clinical Trial. Optometry and Vision Science: Official Publication of the American Academy of Optometry, 93(4), 344–352.
[xxxiii] Lam, C. S. Y., Tang, W. C., Tse, D. Y.-Y., Tang, Y. Y., & To, C. H. (2014). Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. The British Journal of Ophthalmology, 98(1), 40–45.
